Preclinical Efficacy of Recombinant Human Platelet-Derived Growth Factor-BB in Experimental Diabetic Wound Healing: A Systematic Review and Meta-Analysis of Animal Studies
José Luis Muñoz-Carrillo · Oscar Gutiérrez-Coronado · Edrei Lopez-Hernandez · Rosalinda Gutiérrez-Hernández · y 6 más
Background/Objectives: Recombinant human platelet-derived growth factor-BB (rhPDGF-BB) is intended to restore reparative signaling in diabetic wounds, yet its efficacy and the contribution of delivery systems remain uncertain. This systematic review evaluated its preclinical efficacy, mechanistic responses, safety, ris...
- MDPI AG
- English
- DOI: 10.3390/ph19091497